CORDIS · 212111 · FP7
BBMRI Biobanking and Biomolecular Resources Research Infrastructure
Coordinator: MEDIZINISCHE UNIVERSITAT GRAZ (AT)
The Preparatory Phase for a pan-European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) will focus on technical, legal, governance, and financial issues to • prepare to construct BBMRI, building on existing biobanks, resources and technologies, specifically complemented with innovative components and properly embedded into European scientific, ethical, legal and societal frameworks, • provide the concept for a key resource to increase excellence and efficacy in biomedical sciences, drug development and public health, • expand and secure competitiveness of European resea…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
EU contribution: €5.0M awarded to the consortium. The project runs over approximately 3 years from 2008-02-01 to 2011-01-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from AT
see all →- EMPOWER — Eco-operated, Modular, highly efficient, and flexible multi-POWERtrain for long-haul heavy-duty vehicles101096028 · HORIZON · €18.0M
- M-ERA.NET3 — ERA-NET for research and innovation on materials and battery technologies, supporting the European Green Deal.958174 · H2020 · €15.0M
- iPC — individualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology826121 · H2020 · €14.7M
- MORE-TEM — MOmentum and position REsolved mapping Transmission Electron energy loss Microscope951215 · H2020 · €14.0M
- PoCCardio — Personalised Medicine by using an Advanced Point-of-Care Tool for Stratified Treatment in High Risk Cardiovascular Patients (PoCCardio)101095432 · HORIZON · €14.0M
- ThoriumNuclearClock — Thorium nuclear clocks for fundamental tests of physics856415 · H2020 · €13.8M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the CP-CSA-Infra funding scheme.
- What is the EU contribution?
- The European Commission contributes €5.0M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by MEDIZINISCHE UNIVERSITAT GRAZ (AT).
- What is the project timeline?
- The project runs from 2008-02-01 to 2011-01-31 — approximately 3 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 212111.